Study: Half of adults without diabetes taking weight-loss drug discontinue treatment within a year
Sănătate
European Association for the Study of Diabetes Sep 15 2025 The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept) finds that half of adults without diabetes who start taking the weight-loss drug semaglutide in Denmark discontinue
astăzi